Understanding ZSCAN29: A Potential Drug Target for Neurological Disorders

Target Name: ZSCAN29

NCBI ID: G146050

ZSCAN29

Understanding ZSCAN29: A Potential Drug Target for Neurological Disorders

ZSCAN29 (ZNF690) is a protein that is expressed in various tissues throughout the body. It is a key regulator of neural development and has been linked to a number of neurological disorders, including autism. ZSCAN29 has also been identified as a potential drug target for treating a variety of neurological conditions.

The ZNF690 protein is a member of the TCF- transcription factor family, which is a family of proteins that are involved in regulating gene expression. ZNF690 is a 21-kDa protein that is expressed in a variety of tissues, including brain, heart, and muscle. It is highly conserved and has a similar structure to other proteins in the TCF- family.

ZSCAN29 is involved in a number of important processes in the body, including cell proliferation, differentiation, and survival. It has been shown to play a role in the development and maintenance of neural stem cells, which are important for the development and repair of the nervous system.

In addition to its role in neural development, ZSCAN29 has also been linked to a number of neurological disorders. For example, it has been shown to be involved in the development of autism, a neurodevelopmental disorder that is characterized by difficulties with social interaction and communication.

ZSCAN29 has also been linked to a number of other neurological disorders, including epilepsy, schizophrenia, and Parkinson's disease. It has been shown to be involved in the regulation of neurotransmitter systems, which are the chemical messengers that transmit signals between neurons.

Despite these promising findings, much more research is needed to fully understand the role of ZSCAN29 in neurological disorders. One of the challenges in studying this protein is its complex structure, which makes it difficult to study. In addition, the functions of ZSCAN29 are not well understood, which can make it difficult to predict how it might be used as a drug.

In conclusion, ZSCAN29 is a protein that has been identified as a potential drug target for a variety of neurological conditions. Further research is needed to fully understand its role and to develop safe and effective treatments for the disorders that are associated with its dysfunction.

Protein Name: Zinc Finger And SCAN Domain Containing 29

Functions: May be involved in transcriptional regulation

The "ZSCAN29 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN29 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets